Moreover, we explored the correlation between ZNF677 expression and clinico-pathological parameters and sought to determine if ZNF677 could be utilized as a biomarker to predict lymph node metastasis in CRC. This evidence concerns the gene ZNF677 and metastatic malignant neoplasm in the lymph nodes.